Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.80 EPS (ttm)6.69 Insider Own0.08% Shs Outstand2.63B Perf Week-1.97%
Market Cap417.85B Forward P/E15.33 EPS next Y10.39 Insider Trans0.00% Shs Float2.63B Perf Month-2.77%
Income17.88B PEG2.91 EPS next Q2.64 Inst Own70.00% Short Float0.63% Perf Quarter-7.94%
Sales91.45B P/S4.57 EPS this Y-4.20% Inst Trans0.82% Short Ratio2.51 Perf Half Y-5.94%
Book/sh26.69 P/B5.96 EPS next Y5.96% ROA10.20% Target Price187.76 Perf Year10.80%
Cash/sh11.81 P/C13.48 EPS next 5Y8.19% ROE26.60% 52W Range142.86 - 179.92 Perf YTD1.16%
Dividend4.24 P/FCF36.14 EPS past 5Y-0.30% ROI14.60% 52W High-11.52% Beta0.71
Dividend %2.66% Quick Ratio1.10 Sales past 5Y3.30% Gross Margin67.50% 52W Low11.44% ATR2.39
Employees134500 Current Ratio1.30 Sales Q/Q10.70% Oper. Margin21.40% RSI (14)38.33 Volatility1.30% 1.49%
OptionableYes Debt/Eq0.48 EPS Q/Q3.00% Profit Margin19.60% Rel Volume1.29 Prev Close160.24
ShortableYes LT Debt/Eq0.43 EarningsOct 19 BMO Payout61.30% Avg Volume6.59M Price159.20
Recom2.10 SMA20-2.35% SMA50-2.11% SMA200-3.98% Volume8,472,526 Change-0.65%
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-28-21 03:48AM  
Nov-26-21 01:32PM  
11:40AM  
10:53AM  
10:40AM  
10:23AM  
09:42AM  
09:30AM  
09:27AM  
09:19AM  
09:17AM  
07:15AM  
07:13AM  
05:48AM  
Nov-25-21 09:09AM  
08:56AM  
Nov-24-21 04:55PM  
04:50PM  
03:14PM  
12:47PM  
11:00AM  
10:59AM  
10:23AM  
10:16AM  
08:03AM  
07:55AM  
07:07AM  
Nov-23-21 11:55PM  
04:30PM  
12:12PM  
11:58AM  
11:55AM  
10:26AM  
07:00AM  
06:23AM  
Nov-22-21 04:26PM  
04:20PM  
03:53PM  
03:25PM  
01:52PM  
11:04AM  
10:35AM  
10:21AM  
10:02AM  
08:40AM  
08:35AM  
08:12AM  
05:56AM  
05:08AM  
Nov-21-21 11:51AM  
01:00AM  
Nov-20-21 07:09PM  
06:40AM  
Nov-19-21 03:52PM  
10:42AM  
10:34AM  
06:29AM  
Nov-18-21 08:03PM  
04:34PM  
04:13PM  
03:08PM  
01:56PM  
12:20PM  
11:30AM  
10:24AM  
08:09AM  
08:00AM  
05:36AM  
05:30AM  
Nov-17-21 06:08PM  
01:58PM  
01:39PM  
01:10PM  
12:37PM  
10:25AM  
05:55AM  
Nov-16-21 03:13PM  
02:41PM  
Nov-15-21 06:55PM  
02:30PM  
02:29PM  
01:18PM  
10:46AM  
09:41AM  
06:43AM  
06:01AM  
06:00AM  
Nov-14-21 11:32PM  
09:36PM  
04:27PM  
01:18PM  
Nov-13-21 04:02PM  
07:00AM  
02:15AM  
Nov-12-21 08:15PM  
07:58PM  
06:51PM  
06:05PM  
05:45PM  
05:15PM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM